Global Measles, Mumps and Rubella (MMR) Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2021-2027

Report Description


The Global Measles, Mumps and Rubella (MMR) Vaccines Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Measles, Mumps and Rubella (MMR) Vaccines Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Measles, Mumps and Rubella (MMR) Vaccines Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Measles, Mumps and Rubella (MMR) Vaccines Market product affairs. The report is at risk of project regarding this Measles, Mumps and Rubella (MMR) Vaccines Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Medlmmune
  • Johnson & Johnson
  • Merck
  • Sanofi
  • Serum
  • Bavarian Nordic
  • Astellas Pharma
  • Emergent BioSolutions
  • GlaxoSmithKline
  • Pfizer
  • CSL

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Measles, Mumps and Rubella (MMR) Vaccines related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Measles, Mumps and Rubella (MMR) Vaccines Market

Measles, Mumps and Rubella (MMR) Vaccines Market

Report Highlights:


The Measles, Mumps and Rubella (MMR) Vaccines Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Measles, Mumps and Rubella (MMR) Vaccines Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Measles, Mumps and Rubella (MMR) Vaccines Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Measles, Mumps and Rubella (MMR) Vaccines Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Measles, Mumps and Rubella (MMR) Vaccines marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Measles, Mumps and Rubella (MMR) Vaccines market using a bottom-up approach, wherein manufacturers value data for different type (Immune Center, Vaccine Development Agencies and Organizations, Hospital, Laboratory, Biotechnology and Biopharmaceutical Companies), of Measles, Mumps and Rubella (MMR) Vaccines market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Measles, Mumps and Rubella (MMR) Vaccines Market

Measles, Mumps and Rubella (MMR) Vaccines Market

Key Target Audience:


  • Measles, Mumps and Rubella (MMR) Vaccines market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Measles, Mumps and Rubella (MMR) Vaccines market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Measles, Mumps and Rubella (MMR) Vaccines market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Measles, Mumps and Rubella (MMR) Vaccines market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Immune Center
  • Vaccine Development Agencies and Organizations
  • Hospital
  • Laboratory
  • Biotechnology and Biopharmaceutical Companies

By end-user also classify into, the Global Measles, Mumps and Rubella (MMR) Vaccines market:


Global Measles, Mumps and Rubella (MMR) Vaccines market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Monovalent Vaccine
  • Polyvalent Vaccine

Highlights of this 2021-2027 Measles, Mumps and Rubella (MMR) Vaccines Market Report:

  • Market dynamics, Measles, Mumps and Rubella (MMR) Vaccines economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Measles, Mumps and Rubella (MMR) Vaccines industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Measles, Mumps and Rubella (MMR) Vaccines Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Measles, Mumps and Rubella (MMR) Vaccines businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Measles, Mumps and Rubella (MMR) Vaccines market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

TableofContents 1ReportOverview
1.1ResearchScope
1.2TopMeasles,MumpsandRubella(MMR)VaccinesManufacturersCovered:RankingbyRevenue
1.3MarketSegmentbyType
1.3.1GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketSizebyType:2016VS2021VS2027(US$Million)
1.3.2MonovalentVaccine
1.3.3PolyvalentVaccine
1.4MarketSegmentbyApplication
1.4.1GlobalMeasles,MumpsandRubella(MMR)VaccinesConsumptionbyApplication:2016VS2021VS2027
1.4.2ImmuneCenter
1.4.3VaccineDevelopmentAgenciesandOrganizations
1.4.4Hospital
1.4.5Laboratory
1.4.6BiotechnologyandBiopharmaceuticalCompanies
1.5StudyObjectives
1.6YearsConsidered 2GlobalMarketPerspective
2.1GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenue(2016-2027)
2.1.1GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenue(2016-2027)
2.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSales(2016-2027)
2.2Measles,MumpsandRubella(MMR)VaccinesMarketSizeacrossKeyGeographiesWorldwide:2016VS2021VS2027
2.2.1GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesbyRegions(2016-2021)
2.2.2GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenuebyRegions(2016-2021)
2.3GlobalTopMeasles,MumpsandRubella(MMR)VaccinesRegions(Countries)RankingbyMarketSize
2.4Measles,MumpsandRubella(MMR)VaccinesIndustryTrends
2.4.1Measles,MumpsandRubella(MMR)VaccinesMarketTopTrends
2.4.2MarketDrivers
2.4.3Measles,MumpsandRubella(MMR)VaccinesMarketChallenges 2.4.4PortersFiveForcesAnalysis
2.4.5PrimaryInterviewswithKeyMeasles,MumpsandRubella(MMR)VaccinesPlayers:ViewsforFuture 3CompetitiveLandscapebyManufacturers
3.1GlobalTopMeasles,MumpsandRubella(MMR)VaccinesManufacturersbySales(2016-2021)
3.1.1GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesbyManufacturers(2016-2021)
3.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesMarketSharebyManufacturers(2016-2021)
3.1.3Global5and10LargestManufacturersbyMeasles,MumpsandRubella(MMR)VaccinesSalesin2020
3.2GlobalTopManufacturersMeasles,MumpsandRubella(MMR)VaccinesbyRevenue
3.2.1GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenuebyManufacturers(2016-2021)
3.2.2GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueSharebyManufacturers(2016-2021)
3.2.3GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketConcentrationRatio(CR5andHHI)
3.3GlobalTopManufacturersbyCompanyType(Tier1,Tier2andTier3)(basedontheRevenueinMeasles,MumpsandRubella(MMR)Vaccinesasof2020)
3.4GlobalMeasles,MumpsandRubella(MMR)VaccinesAverageSellingPrice(ASP)byManufacturers
3.5KeyManufacturersMeasles,MumpsandRubella(MMR)VaccinesPlants/FactoriesDistributionandAreaServed
3.6DateofKeyManufacturersEnterintoMeasles,MumpsandRubella(MMR)VaccinesMarket
3.7KeyManufacturersMeasles,MumpsandRubella(MMR)VaccinesProductOffered 3.8Mergers&Acquisitions,ExpansionPlans 4MarketSizebyType
4.1GlobalMeasles,MumpsandRubella(MMR)VaccinesHistoricMarketReviewbyType(2016-2021)
4.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesMarketSharebyType(2016-2021)
4.1.3GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueMarketSharebyType(2016-2021)
4.1.4Measles,MumpsandRubella(MMR)VaccinesPricebyType(2016-2021)
4.1GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketEstimatesandForecastsbyType(2021-2027)
4.2.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesForecastbyType(2021-2027)
4.2.3GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueForecastbyType(2021-2027)
4.2.4Measles,MumpsandRubella(MMR)VaccinesPriceForecastbyType(2021-2027) 5GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketSizebyApplication
5.1GlobalMeasles,MumpsandRubella(MMR)VaccinesHistoricMarketReviewbyApplication(2016-2021)
5.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesMarketSharebyApplication(2016-2021)
5.1.3GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueMarketSharebyApplication(2016-2021)
5.1.4Measles,MumpsandRubella(MMR)VaccinesPricebyApplication(2016-2021)
5.2GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketEstimatesandForecastsbyApplication(2021-2027)
5.2.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesForecastbyApplication(2021-2027)
5.2.3GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueForecastbyApplication(2021-2027)
5.2.4Measles,MumpsandRubella(MMR)VaccinesPriceForecastbyApplication(2021-2027) 6NorthAmerica
6.1NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCompany
6.2NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
6.3NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
6.4NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCountries
6.4.1NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesSalesbyCountries
6.4.2NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesRevenuebyCountries
6.4.3U.S.
6.4.4Canada 7Europe
7.1EuropeMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCompany
7.2EuropeMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
7.3EuropeMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
7.4EuropeMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCountries
7.4.1EuropeMeasles,MumpsandRubella(MMR)VaccinesSalesbyCountries
7.4.2EuropeMeasles,MumpsandRubella(MMR)VaccinesRevenuebyCountries
7.4.3Germany
7.4.4France
7.4.5U.K.
7.4.6Italy
7.4.7Russia 8AsiaPacific
8.1AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCompany
8.2AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
8.3AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
8.4AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyRegions
8.4.1AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesSalesbyRegions
8.4.2AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesRevenuebyRegions
8.4.3China
8.4.4Japan
8.4.5SouthKorea
8.4.6India
8.4.7Australia
8.4.8Taiwan
8.4.9Indonesia
8.4.10Thailand
8.4.11Malaysia
8.4.12Philippines
8.4.13Vietnam 9LatinAmerica
9.1LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCompany
9.2LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
9.3LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
9.4LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCountries
9.4.1LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesSalesbyCountries
9.4.2LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesRevenuebyCountries
9.4.3Mexico
9.4.4Brazil
9.4.5Argentina 10MiddleEastandAfrica
10.1MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
10.2MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
10.3MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCountries
10.3.1MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesSalesbyCountries
10.3.2MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesRevenuebyCountries
10.3.3Turkey
10.3.4SaudiArabia
10.3.5U.A.E 11CompanyProfiles
11.1Medlmmune
11.1.1MedlmmuneCorporationInformation
11.1.2MedlmmuneBusinessOverviewandTotalRevenue(2020VS2019)
11.1.3MedlmmuneMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.1.4MedlmmuneMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.1.5MedlmmuneSWOTAnalysis
11.1.6MedlmmuneRecentDevelopments
11.2Johnson&Johnson
11.2.1Johnson&JohnsonCorporationInformation
11.2.2Johnson&JohnsonBusinessOverviewandTotalRevenue(2020VS2019)
11.2.3Johnson&JohnsonMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.2.4Johnson&JohnsonMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.2.5Johnson&JohnsonSWOTAnalysis
11.2.6Johnson&JohnsonRecentDevelopments
11.3Merck
11.3.1MerckCorporationInformation
11.3.2MerckBusinessOverviewandTotalRevenue(2020VS2019)
11.3.3MerckMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.3.4MerckMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.3.5MerckSWOTAnalysis
11.3.6MerckRecentDevelopments
11.4Sanofi
11.4.1SanofiCorporationInformation
11.4.2SanofiBusinessOverviewandTotalRevenue(2020VS2019)
11.4.3SanofiMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.4.4SanofiMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.4.5SanofiSWOTAnalysis
11.4.6SanofiRecentDevelopments
11.5Serum
11.5.1SerumCorporationInformation
11.5.2SerumBusinessOverviewandTotalRevenue(2020VS2019)
11.5.3SerumMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.5.4SerumMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.5.5SerumSWOTAnalysis
11.5.6SerumRecentDevelopments
11.6BavarianNordic
11.6.1BavarianNordicCorporationInformation
11.6.2BavarianNordicBusinessOverviewandTotalRevenue(2020VS2019)
11.6.3BavarianNordicMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.6.4BavarianNordicMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.6.5BavarianNordicSWOTAnalysis
11.6.6BavarianNordicRecentDevelopments
11.7AstellasPharma
11.7.1AstellasPharmaCorporationInformation
11.7.2AstellasPharmaBusinessOverviewandTotalRevenue(2020VS2019)
11.7.3AstellasPharmaMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.7.4AstellasPharmaMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.7.5AstellasPharmaSWOTAnalysis
11.7.6AstellasPharmaRecentDevelopments
11.8EmergentBioSolutions
11.8.1EmergentBioSolutionsCorporationInformation
11.8.2EmergentBioSolutionsBusinessOverviewandTotalRevenue(2020VS2019)
11.8.3EmergentBioSolutionsMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.8.4EmergentBioSolutionsMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.8.5EmergentBioSolutionsSWOTAnalysis
11.8.6EmergentBioSolutionsRecentDevelopments
11.9GlaxoSmithKline
11.9.1GlaxoSmithKlineCorporationInformation
11.9.2GlaxoSmithKlineBusinessOverviewandTotalRevenue(2020VS2019)
11.9.3GlaxoSmithKlineMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.9.4GlaxoSmithKlineMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.9.5GlaxoSmithKlineSWOTAnalysis
11.9.6GlaxoSmithKlineRecentDevelopments
11.10Pfizer
11.10.1PfizerCorporationInformation
11.10.2PfizerBusinessOverviewandTotalRevenue(2020VS2019)
11.10.3PfizerMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.10.4PfizerMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.10.5PfizerSWOTAnalysis
11.10.6PfizerRecentDevelopments
11.11CSL
11.11.1CSLCorporationInformation
11.11.2CSLBusinessOverviewandTotalRevenue(2020VS2019)
11.11.3CSLMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.11.4CSLMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.11.5CSLSWOTAnalysis
11.11.6CSLRecentDevelopments 12SupplyChainandSalesChannelsAnalysis 12.1SupplyChainAnalysis 12.2SalesChannelsAnalysis
12.2.1Measles,MumpsandRubella(MMR)VaccinesSalesChannels
12.2.2Measles,MumpsandRubella(MMR)VaccinesDistributors
12.3Measles,MumpsandRubella(MMR)VaccinesCustomers 13EstimatesandProjectionsbyRegions(2021-2027)
13.1GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.1.1GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesForecastbyRegions(2021-2027)
13.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueForecastbyRegions(2021-2027) 13.2NorthAmericaMarketSizeForecast(2021-2027)
13.2.1NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.2.2NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.2.3NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyCounty(2021-2027) 13.3EuropeMarketSizeForecast(2021-2027)
13.3.1EuropeMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.3.2EuropeMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.3.3EuropeMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyCounty(2021-2027) 13.4AsiaPacificMarketSizeForecast(2021-2027)
13.4.1AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.4.2AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.4.3AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyRegion(2021-2027) 13.5LatinAmericaMarketSizeForecast(2021-2027)
13.5.1LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.5.2LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.5.3LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyCounty(2021-2027) 13.6MiddleEastandAfricaMarketForecast
13.6.1MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.6.2MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.6.3MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyCounty(2021-2027) 14ResearchFindingsandConclusion 15Appendix
15.1ResearchMethodology
15.1.1Methodology/ResearchApproach
15.1.2DataSource
15.2AuthorDetails
15.3Disclaimer

List of Tables
Table 1. Measles, Mumps and Rubella (MMR) Vaccines Key Market Segments
Table 2. Ranking of Global Top Measles, Mumps and Rubella (MMR) Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Type 2021-2027 (K Doses) & (Million US$)
Table 4. Major Manufacturers of Monovalent Vaccine
Table 5. Major Manufacturers of Polyvalent Vaccine
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application 2020-2025 (K Doses)
Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Regions 2016-2021 (K Doses) & (Million US$)
Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Regions 2016-2021 (K Doses)
Table 9. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions 2016-2021
Table 10. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Regions 2016-2021 (Million US$)
Table 11. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Regions 2016-2021
Table 12. Top Measles, Mumps and Rubella (MMR) Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2020
Table 13. Market Top Trends
Table 14. Measles, Mumps and Rubella (MMR) Vaccines Key Drivers: Impact Analysis (2021-2027)
Table 15. Measles, Mumps and Rubella (MMR) Vaccines Key Challenges
Table 16. Main Points Interviewed from Key Measles, Mumps and Rubella (MMR) Vaccines Players: Views for Future
Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers (2016-2021) (K Doses)
Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers (2016-2021)
Table 19. Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers (2016-2021) (Million US$)
Table 20. Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2016-2021)
Table 21. Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2020)
Table 23. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) (2016-2021) (USD/Dose)
Table 24. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Plants/Factories Distribution
Table 25. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Area Served
Table 26. Date of Key Manufacturers Enter into Measles, Mumps and Rubella (MMR) Vaccines Market
Table 27. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Monovalent Vaccine Sales and Revenue (2016-2021) (K Doses) & (Million US$)
Table 30. Global Polyvalent Vaccine Sales and Revenue (2016-2021) (K Doses) & (Million US$)
Table 31. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2016-2021)
Table 32. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2016-2021)
Table 33. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 34. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Type (2016-2021)
Table 35. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2021-2027)
Table 36. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2021-2027)
Table 37. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2021-2027)
Table 38. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2021-2027)
Table 39. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Type (2021-2027)
Table 40. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2016-2021)
Table 41. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2016-2021)
Table 42. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 43. Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application 2016-2021 (USD/Dose)
Table 44. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 45. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2016-2021)
Table 46. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2021-2027)
Table 47. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2021-2027)
Table 48. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Application (2021-2027)
Table 49. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021) (K Doses)
Table 50. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 51. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 52. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 53. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 54. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 55. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 56. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2016-2021)
Table 57. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2016-2021) (Million US$)
Table 58. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2016-2021)
Table 59. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021) (K Doses)
Table 60. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 61. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 62. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 63. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 64. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 65. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 66. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2016-2021)
Table 67. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2016-2021) (Million US$)
Table 68. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2016-2021)
Table 69. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Regions (2016-2021) (K Doses)
Table 70. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions (2016-2021)
Table 71. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 72. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 73. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 74. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 75. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 76. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions (2016-2021)
Table 77. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Regions (2016-2021) (Million US$)
Table 78. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Regions (2016-2021)
Table 79. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021) (K Doses)
Table 80. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 81. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 82. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 83. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 84. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 85. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 86. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2016-2021)
Table 87. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2016-2021) (Million US$)
Table 88. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2016-2021)
Table 89. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 90. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 91. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 92. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 93. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 94. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2016-2021)
Table 95. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2016-2021) (Million US$)
Table 96. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2016-2021)
Table 97. Medlmmune Company Details
Table 98. Medlmmune Description and Business Overview
Table 99. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 100. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 101. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 102. Medlmmune Recent Development
Table 103. Johnson & Johnson Company Details
Table 104. Johnson & Johnson Description and Business Overview
Table 105. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 107. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 108. Johnson & Johnson Recent Development
Table 109. Merck Company Details
Table 110. Merck Description and Business Overview
Table 111. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 112. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 113. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 114. Merck Recent Development
Table 115. Sanofi Company Details
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 119. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 120. Sanofi Recent Development
Table 121. Serum Company Details
Table 122. Serum Description and Business Overview
Table 123. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 124. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 125. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 126. Serum Recent Development
Table 127. Bavarian Nordic Company Details
Table 128. Bavarian Nordic Description and Business Overview
Table 129. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 130. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 131. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 132. Bavarian Nordic Recent Development
Table 133. Astellas Pharma Company Details
Table 134. Astellas Pharma Description and Business Overview
Table 135. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 137. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 138. Astellas Pharma Recent Development
Table 139. Emergent BioSolutions Company Details
Table 140. Emergent BioSolutions Description and Business Overview
Table 141. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 142. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 143. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 144. Emergent BioSolutions Recent Development
Table 145. GlaxoSmithKline Company Details
Table 146. GlaxoSmithKline Description and Business Overview
Table 147. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 148. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 149. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 150. GlaxoSmithKline Recent Development
Table 151. Pfizer Company Details
Table 152. Pfizer Description and Business Overview
Table 153. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 154. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 155. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 156. Pfizer Recent Development
Table 157. CSL Company Details
Table 158. CSL Description and Business Overview
Table 159. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 160. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 161. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 162. CSL Recent Development
Table 163. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
Table 164. Measles, Mumps and Rubella (MMR) Vaccines Customers List
Table 165. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast 2021-2027 (K Doses) & (Million US$)
Table 166. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type 2021-2027 (K Doses)
Table 167. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application 2021-2027 (K Doses)
Table 168. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions 2021-2027 (K Doses)
Table 169. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Regions 2021-2027 (Million US$)
Table 170. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Countries 2021-2027 (K Doses)
Table 171. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Countries 2021-2027
Table 172. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Countries 2021-2027 (K Doses)
Table 173. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Countries 2021-2027
Table 174. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions 2021-2027 (K Doses)
Table 175. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Regions 2021-2027 (Million US$)
Table 176. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Countries 2021-2027 (K Doses)
Table 177. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Countries 2021-2027 (Million US$)
Table 178. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions 2021-2027 (K Doses)
Table 179. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Regions 2021-2027 (Million US$)
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Product Picture
Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Shar by Type 2016-2027
Figure 3. Monovalent Vaccine Figures
Figure 4. Polyvalent Vaccine Figures
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2020 & 2027
Figure 6. Immune Center Use Case
Figure 7. Vaccine Development Agencies and Organizations Use Case
Figure 8. Hospital Use Case
Figure 9. Laboratory Use Case
Figure 10. Biotechnology and Biopharmaceutical Companies Use Case
Figure 11. Measles, Mumps and Rubella (MMR) Vaccines Report Years Considered
Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size 2016-2027 (Million US$)
Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2016-2021 (K Doses)
Figure 14. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Market Share by Regions 2016-2021
Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions in 2020
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers in 2020
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Measles, Mumps and Rubella (MMR) Vaccines Sales in 2020
Figure 19. Measles, Mumps and Rubella (MMR) Vaccines Value Share by Manufacturers in 2020
Figure 20. Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers In 2020
Figure 21. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2016-2021)
Figure 23. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 24. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Price Range (2016-2021)
Figure 25. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2016-2021)
Figure 26. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 27. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 28. U.S. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 29. Canada Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 30. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 31. Germany Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 32. France Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 33. U.K. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 34. Italy Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 35. Russia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 36. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 37. China Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 38. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 39. South Korea Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 40. India Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 41. Australia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 42. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 43. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 44. Thailand Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 45. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 46. Philippines Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 47. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 48. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 49. Mexico Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 50. Brazil Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 51. Argentina Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 52. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 53. Turkey Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 54. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 55. U.A.E Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 56. Medlmmune Total Revenue (US$ Million): 2020 Compared with 2019
Figure 57. Johnson & Johnson Total Revenue (US$ Million): 2020 Compared with 2019
Figure 58. Merck Total Revenue (US$ Million): 2020 Compared with 2019
Figure 59. Sanofi Total Revenue (US$ Million): 2020 Compared with 2019
Figure 60. Serum Total Revenue (US$ Million): 2020 Compared with 2019
Figure 61. Bavarian Nordic Total Revenue (US$ Million): 2020 Compared with 2019
Figure 62. Astellas Pharma Total Revenue (US$ Million): 2020 Compared with 2019
Figure 63. Emergent BioSolutions Total Revenue (US$ Million): 2020 Compared with 2019
Figure 64. GlaxoSmithKline Total Revenue (US$ Million): 2020 Compared with 2019
Figure 65. Pfizer Total Revenue (US$ Million): 2020 Compared with 2019
Figure 66. CSL Total Revenue (US$ Million): 2020 Compared with 2019
Figure 67. Measles, Mumps and Rubella (MMR) Vaccines Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 71. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 72. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 73. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 74. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 75. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 76. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 77. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 78. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 79. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

Measles, Mumps and Rubella (MMR) Vaccines Market Segments


Measles, Mumps and Rubella (MMR) Vaccines Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Immune Center
  • Vaccine Development Agencies and Organizations
  • Hospital
  • Laboratory
  • Biotechnology and Biopharmaceutical Companies

Measles, Mumps and Rubella (MMR) Vaccines Application Outlook (Revenue, USD Million, 2021 2027)


  • Monovalent Vaccine
  • Polyvalent Vaccine

Measles, Mumps and Rubella (MMR) Vaccines Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

  • Europe
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

  • Asia Pacific
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

  • Latin America
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

  • Middle East & Africa
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global Measles, Mumps and Rubella (MMR) Vaccines Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global Measles, Mumps and Rubella (MMR) Vaccines Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.

New traders at intervals the Measles, Mumps and Rubella (MMR) Vaccines Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of Measles, Mumps and Rubella (MMR) Vaccines Market product affairs. The report is at risk of project regarding this Measles, Mumps and Rubella (MMR) Vaccines Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • Medlmmune
  • Johnson & Johnson
  • Merck
  • Sanofi
  • Serum
  • Bavarian Nordic
  • Astellas Pharma
  • Emergent BioSolutions
  • GlaxoSmithKline
  • Pfizer
  • CSL

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as Measles, Mumps and Rubella (MMR) Vaccines related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


Measles, Mumps and Rubella (MMR) Vaccines Market

Measles, Mumps and Rubella (MMR) Vaccines Market

Report Highlights:


The Measles, Mumps and Rubella (MMR) Vaccines Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The Measles, Mumps and Rubella (MMR) Vaccines Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive Measles, Mumps and Rubella (MMR) Vaccines Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of Measles, Mumps and Rubella (MMR) Vaccines Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and Measles, Mumps and Rubella (MMR) Vaccines marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the Measles, Mumps and Rubella (MMR) Vaccines market using a bottom-up approach, wherein manufacturers value data for different type (Immune Center, Vaccine Development Agencies and Organizations, Hospital, Laboratory, Biotechnology and Biopharmaceutical Companies), of Measles, Mumps and Rubella (MMR) Vaccines market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

Measles, Mumps and Rubella (MMR) Vaccines Market

Measles, Mumps and Rubella (MMR) Vaccines Market

Key Target Audience:


  • Measles, Mumps and Rubella (MMR) Vaccines market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the Measles, Mumps and Rubella (MMR) Vaccines market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, Measles, Mumps and Rubella (MMR) Vaccines market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global Measles, Mumps and Rubella (MMR) Vaccines market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Immune Center
  • Vaccine Development Agencies and Organizations
  • Hospital
  • Laboratory
  • Biotechnology and Biopharmaceutical Companies

By end-user also classify into, the Global Measles, Mumps and Rubella (MMR) Vaccines market:


Global Measles, Mumps and Rubella (MMR) Vaccines market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Monovalent Vaccine
  • Polyvalent Vaccine

Highlights of this 2021-2027 Measles, Mumps and Rubella (MMR) Vaccines Market Report:

  • Market dynamics, Measles, Mumps and Rubella (MMR) Vaccines economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • Measles, Mumps and Rubella (MMR) Vaccines industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide Measles, Mumps and Rubella (MMR) Vaccines Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading Measles, Mumps and Rubella (MMR) Vaccines businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the Measles, Mumps and Rubella (MMR) Vaccines market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com
TableofContents 1ReportOverview
1.1ResearchScope
1.2TopMeasles,MumpsandRubella(MMR)VaccinesManufacturersCovered:RankingbyRevenue
1.3MarketSegmentbyType
1.3.1GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketSizebyType:2016VS2021VS2027(US$Million)
1.3.2MonovalentVaccine
1.3.3PolyvalentVaccine
1.4MarketSegmentbyApplication
1.4.1GlobalMeasles,MumpsandRubella(MMR)VaccinesConsumptionbyApplication:2016VS2021VS2027
1.4.2ImmuneCenter
1.4.3VaccineDevelopmentAgenciesandOrganizations
1.4.4Hospital
1.4.5Laboratory
1.4.6BiotechnologyandBiopharmaceuticalCompanies
1.5StudyObjectives
1.6YearsConsidered 2GlobalMarketPerspective
2.1GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenue(2016-2027)
2.1.1GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenue(2016-2027)
2.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSales(2016-2027)
2.2Measles,MumpsandRubella(MMR)VaccinesMarketSizeacrossKeyGeographiesWorldwide:2016VS2021VS2027
2.2.1GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesbyRegions(2016-2021)
2.2.2GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenuebyRegions(2016-2021)
2.3GlobalTopMeasles,MumpsandRubella(MMR)VaccinesRegions(Countries)RankingbyMarketSize
2.4Measles,MumpsandRubella(MMR)VaccinesIndustryTrends
2.4.1Measles,MumpsandRubella(MMR)VaccinesMarketTopTrends
2.4.2MarketDrivers
2.4.3Measles,MumpsandRubella(MMR)VaccinesMarketChallenges 2.4.4PortersFiveForcesAnalysis
2.4.5PrimaryInterviewswithKeyMeasles,MumpsandRubella(MMR)VaccinesPlayers:ViewsforFuture 3CompetitiveLandscapebyManufacturers
3.1GlobalTopMeasles,MumpsandRubella(MMR)VaccinesManufacturersbySales(2016-2021)
3.1.1GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesbyManufacturers(2016-2021)
3.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesMarketSharebyManufacturers(2016-2021)
3.1.3Global5and10LargestManufacturersbyMeasles,MumpsandRubella(MMR)VaccinesSalesin2020
3.2GlobalTopManufacturersMeasles,MumpsandRubella(MMR)VaccinesbyRevenue
3.2.1GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenuebyManufacturers(2016-2021)
3.2.2GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueSharebyManufacturers(2016-2021)
3.2.3GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketConcentrationRatio(CR5andHHI)
3.3GlobalTopManufacturersbyCompanyType(Tier1,Tier2andTier3)(basedontheRevenueinMeasles,MumpsandRubella(MMR)Vaccinesasof2020)
3.4GlobalMeasles,MumpsandRubella(MMR)VaccinesAverageSellingPrice(ASP)byManufacturers
3.5KeyManufacturersMeasles,MumpsandRubella(MMR)VaccinesPlants/FactoriesDistributionandAreaServed
3.6DateofKeyManufacturersEnterintoMeasles,MumpsandRubella(MMR)VaccinesMarket
3.7KeyManufacturersMeasles,MumpsandRubella(MMR)VaccinesProductOffered 3.8Mergers&Acquisitions,ExpansionPlans 4MarketSizebyType
4.1GlobalMeasles,MumpsandRubella(MMR)VaccinesHistoricMarketReviewbyType(2016-2021)
4.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesMarketSharebyType(2016-2021)
4.1.3GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueMarketSharebyType(2016-2021)
4.1.4Measles,MumpsandRubella(MMR)VaccinesPricebyType(2016-2021)
4.1GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketEstimatesandForecastsbyType(2021-2027)
4.2.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesForecastbyType(2021-2027)
4.2.3GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueForecastbyType(2021-2027)
4.2.4Measles,MumpsandRubella(MMR)VaccinesPriceForecastbyType(2021-2027) 5GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketSizebyApplication
5.1GlobalMeasles,MumpsandRubella(MMR)VaccinesHistoricMarketReviewbyApplication(2016-2021)
5.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesMarketSharebyApplication(2016-2021)
5.1.3GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueMarketSharebyApplication(2016-2021)
5.1.4Measles,MumpsandRubella(MMR)VaccinesPricebyApplication(2016-2021)
5.2GlobalMeasles,MumpsandRubella(MMR)VaccinesMarketEstimatesandForecastsbyApplication(2021-2027)
5.2.2GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesForecastbyApplication(2021-2027)
5.2.3GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueForecastbyApplication(2021-2027)
5.2.4Measles,MumpsandRubella(MMR)VaccinesPriceForecastbyApplication(2021-2027) 6NorthAmerica
6.1NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCompany
6.2NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
6.3NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
6.4NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCountries
6.4.1NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesSalesbyCountries
6.4.2NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesRevenuebyCountries
6.4.3U.S.
6.4.4Canada 7Europe
7.1EuropeMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCompany
7.2EuropeMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
7.3EuropeMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
7.4EuropeMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCountries
7.4.1EuropeMeasles,MumpsandRubella(MMR)VaccinesSalesbyCountries
7.4.2EuropeMeasles,MumpsandRubella(MMR)VaccinesRevenuebyCountries
7.4.3Germany
7.4.4France
7.4.5U.K.
7.4.6Italy
7.4.7Russia 8AsiaPacific
8.1AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCompany
8.2AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
8.3AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
8.4AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyRegions
8.4.1AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesSalesbyRegions
8.4.2AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesRevenuebyRegions
8.4.3China
8.4.4Japan
8.4.5SouthKorea
8.4.6India
8.4.7Australia
8.4.8Taiwan
8.4.9Indonesia
8.4.10Thailand
8.4.11Malaysia
8.4.12Philippines
8.4.13Vietnam 9LatinAmerica
9.1LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCompany
9.2LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
9.3LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
9.4LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCountries
9.4.1LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesSalesbyCountries
9.4.2LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesRevenuebyCountries
9.4.3Mexico
9.4.4Brazil
9.4.5Argentina 10MiddleEastandAfrica
10.1MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyType
10.2MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyApplication
10.3MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesBreakdownDatabyCountries
10.3.1MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesSalesbyCountries
10.3.2MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesRevenuebyCountries
10.3.3Turkey
10.3.4SaudiArabia
10.3.5U.A.E 11CompanyProfiles
11.1Medlmmune
11.1.1MedlmmuneCorporationInformation
11.1.2MedlmmuneBusinessOverviewandTotalRevenue(2020VS2019)
11.1.3MedlmmuneMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.1.4MedlmmuneMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.1.5MedlmmuneSWOTAnalysis
11.1.6MedlmmuneRecentDevelopments
11.2Johnson&Johnson
11.2.1Johnson&JohnsonCorporationInformation
11.2.2Johnson&JohnsonBusinessOverviewandTotalRevenue(2020VS2019)
11.2.3Johnson&JohnsonMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.2.4Johnson&JohnsonMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.2.5Johnson&JohnsonSWOTAnalysis
11.2.6Johnson&JohnsonRecentDevelopments
11.3Merck
11.3.1MerckCorporationInformation
11.3.2MerckBusinessOverviewandTotalRevenue(2020VS2019)
11.3.3MerckMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.3.4MerckMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.3.5MerckSWOTAnalysis
11.3.6MerckRecentDevelopments
11.4Sanofi
11.4.1SanofiCorporationInformation
11.4.2SanofiBusinessOverviewandTotalRevenue(2020VS2019)
11.4.3SanofiMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.4.4SanofiMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.4.5SanofiSWOTAnalysis
11.4.6SanofiRecentDevelopments
11.5Serum
11.5.1SerumCorporationInformation
11.5.2SerumBusinessOverviewandTotalRevenue(2020VS2019)
11.5.3SerumMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.5.4SerumMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.5.5SerumSWOTAnalysis
11.5.6SerumRecentDevelopments
11.6BavarianNordic
11.6.1BavarianNordicCorporationInformation
11.6.2BavarianNordicBusinessOverviewandTotalRevenue(2020VS2019)
11.6.3BavarianNordicMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.6.4BavarianNordicMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.6.5BavarianNordicSWOTAnalysis
11.6.6BavarianNordicRecentDevelopments
11.7AstellasPharma
11.7.1AstellasPharmaCorporationInformation
11.7.2AstellasPharmaBusinessOverviewandTotalRevenue(2020VS2019)
11.7.3AstellasPharmaMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.7.4AstellasPharmaMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.7.5AstellasPharmaSWOTAnalysis
11.7.6AstellasPharmaRecentDevelopments
11.8EmergentBioSolutions
11.8.1EmergentBioSolutionsCorporationInformation
11.8.2EmergentBioSolutionsBusinessOverviewandTotalRevenue(2020VS2019)
11.8.3EmergentBioSolutionsMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.8.4EmergentBioSolutionsMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.8.5EmergentBioSolutionsSWOTAnalysis
11.8.6EmergentBioSolutionsRecentDevelopments
11.9GlaxoSmithKline
11.9.1GlaxoSmithKlineCorporationInformation
11.9.2GlaxoSmithKlineBusinessOverviewandTotalRevenue(2020VS2019)
11.9.3GlaxoSmithKlineMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.9.4GlaxoSmithKlineMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.9.5GlaxoSmithKlineSWOTAnalysis
11.9.6GlaxoSmithKlineRecentDevelopments
11.10Pfizer
11.10.1PfizerCorporationInformation
11.10.2PfizerBusinessOverviewandTotalRevenue(2020VS2019)
11.10.3PfizerMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.10.4PfizerMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.10.5PfizerSWOTAnalysis
11.10.6PfizerRecentDevelopments
11.11CSL
11.11.1CSLCorporationInformation
11.11.2CSLBusinessOverviewandTotalRevenue(2020VS2019)
11.11.3CSLMeasles,MumpsandRubella(MMR)VaccinesSales,Revenue,AverageSellingPrice(ASP)andGrossMargin(2016-2021)
11.11.4CSLMeasles,MumpsandRubella(MMR)VaccinesProductsandServices
11.11.5CSLSWOTAnalysis
11.11.6CSLRecentDevelopments 12SupplyChainandSalesChannelsAnalysis 12.1SupplyChainAnalysis 12.2SalesChannelsAnalysis
12.2.1Measles,MumpsandRubella(MMR)VaccinesSalesChannels
12.2.2Measles,MumpsandRubella(MMR)VaccinesDistributors
12.3Measles,MumpsandRubella(MMR)VaccinesCustomers 13EstimatesandProjectionsbyRegions(2021-2027)
13.1GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.1.1GlobalMeasles,MumpsandRubella(MMR)VaccinesSalesForecastbyRegions(2021-2027)
13.1.2GlobalMeasles,MumpsandRubella(MMR)VaccinesRevenueForecastbyRegions(2021-2027) 13.2NorthAmericaMarketSizeForecast(2021-2027)
13.2.1NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.2.2NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.2.3NorthAmericaMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyCounty(2021-2027) 13.3EuropeMarketSizeForecast(2021-2027)
13.3.1EuropeMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.3.2EuropeMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.3.3EuropeMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyCounty(2021-2027) 13.4AsiaPacificMarketSizeForecast(2021-2027)
13.4.1AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.4.2AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.4.3AsiaPacificMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyRegion(2021-2027) 13.5LatinAmericaMarketSizeForecast(2021-2027)
13.5.1LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.5.2LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.5.3LatinAmericaMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyCounty(2021-2027) 13.6MiddleEastandAfricaMarketForecast
13.6.1MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesSalesForecast(2021-2027)
13.6.2MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesRevenueForecast(2021-2027)
13.6.3MiddleEastandAfricaMeasles,MumpsandRubella(MMR)VaccinesSizeForecastbyCounty(2021-2027) 14ResearchFindingsandConclusion 15Appendix
15.1ResearchMethodology
15.1.1Methodology/ResearchApproach
15.1.2DataSource
15.2AuthorDetails
15.3Disclaimer

Measles, Mumps and Rubella (MMR) Vaccines Market Segments


Measles, Mumps and Rubella (MMR) Vaccines Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Immune Center
  • Vaccine Development Agencies and Organizations
  • Hospital
  • Laboratory
  • Biotechnology and Biopharmaceutical Companies

Measles, Mumps and Rubella (MMR) Vaccines Application Outlook (Revenue, USD Million, 2021 2027)


  • Monovalent Vaccine
  • Polyvalent Vaccine

Measles, Mumps and Rubella (MMR) Vaccines Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

  • Europe
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

  • Asia Pacific
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

  • Latin America
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

  • Middle East & Africa
    • Measles, Mumps and Rubella (MMR) Vaccines market, By Product Type Outlook
      • Immune Center
      • Vaccine Development Agencies and Organizations
      • Hospital
      • Laboratory
      • Biotechnology and Biopharmaceutical Companies

    • Measles, Mumps and Rubella (MMR) Vaccines market, By Application Outlook
      • Monovalent Vaccine
      • Polyvalent Vaccine

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials
List of Tables
Table 1. Measles, Mumps and Rubella (MMR) Vaccines Key Market Segments
Table 2. Ranking of Global Top Measles, Mumps and Rubella (MMR) Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Type 2021-2027 (K Doses) & (Million US$)
Table 4. Major Manufacturers of Monovalent Vaccine
Table 5. Major Manufacturers of Polyvalent Vaccine
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Application 2020-2025 (K Doses)
Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Regions 2016-2021 (K Doses) & (Million US$)
Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Regions 2016-2021 (K Doses)
Table 9. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions 2016-2021
Table 10. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Regions 2016-2021 (Million US$)
Table 11. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Regions 2016-2021
Table 12. Top Measles, Mumps and Rubella (MMR) Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2020
Table 13. Market Top Trends
Table 14. Measles, Mumps and Rubella (MMR) Vaccines Key Drivers: Impact Analysis (2021-2027)
Table 15. Measles, Mumps and Rubella (MMR) Vaccines Key Challenges
Table 16. Main Points Interviewed from Key Measles, Mumps and Rubella (MMR) Vaccines Players: Views for Future
Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers (2016-2021) (K Doses)
Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers (2016-2021)
Table 19. Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers (2016-2021) (Million US$)
Table 20. Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2016-2021)
Table 21. Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2020)
Table 23. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Average Selling Price (ASP) (2016-2021) (USD/Dose)
Table 24. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Plants/Factories Distribution
Table 25. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Area Served
Table 26. Date of Key Manufacturers Enter into Measles, Mumps and Rubella (MMR) Vaccines Market
Table 27. Key Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Monovalent Vaccine Sales and Revenue (2016-2021) (K Doses) & (Million US$)
Table 30. Global Polyvalent Vaccine Sales and Revenue (2016-2021) (K Doses) & (Million US$)
Table 31. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2016-2021)
Table 32. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2016-2021)
Table 33. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 34. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Type (2016-2021)
Table 35. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2021-2027)
Table 36. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2021-2027)
Table 37. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Type (2021-2027)
Table 38. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2021-2027)
Table 39. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Type (2021-2027)
Table 40. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2016-2021)
Table 41. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2016-2021)
Table 42. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 43. Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application 2016-2021 (USD/Dose)
Table 44. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 45. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2016-2021)
Table 46. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (US$ Million) Market Share by Application (2021-2027)
Table 47. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2021-2027)
Table 48. Global Measles, Mumps and Rubella (MMR) Vaccines Price (K Doses) by Application (2021-2027)
Table 49. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021) (K Doses)
Table 50. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 51. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 52. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 53. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 54. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 55. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 56. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2016-2021)
Table 57. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2016-2021) (Million US$)
Table 58. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2016-2021)
Table 59. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021) (K Doses)
Table 60. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 61. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 62. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 63. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 64. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 65. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 66. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2016-2021)
Table 67. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2016-2021) (Million US$)
Table 68. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2016-2021)
Table 69. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Regions (2016-2021) (K Doses)
Table 70. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions (2016-2021)
Table 71. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 72. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 73. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 74. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 75. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 76. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions (2016-2021)
Table 77. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Regions (2016-2021) (Million US$)
Table 78. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Regions (2016-2021)
Table 79. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Company (2016-2021) (K Doses)
Table 80. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Company (2016-2021)
Table 81. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 82. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 83. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 84. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 85. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 86. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2016-2021)
Table 87. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2016-2021) (Million US$)
Table 88. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2016-2021)
Table 89. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2016-2021) (K Doses)
Table 90. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2016-2021)
Table 91. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2016-2021) (K Doses)
Table 92. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2016-2021)
Table 93. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Countries (2016-2021) (K Doses)
Table 94. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Countries (2016-2021)
Table 95. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Countries (2016-2021) (Million US$)
Table 96. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Countries (2016-2021)
Table 97. Medlmmune Company Details
Table 98. Medlmmune Description and Business Overview
Table 99. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 100. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 101. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 102. Medlmmune Recent Development
Table 103. Johnson & Johnson Company Details
Table 104. Johnson & Johnson Description and Business Overview
Table 105. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 107. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 108. Johnson & Johnson Recent Development
Table 109. Merck Company Details
Table 110. Merck Description and Business Overview
Table 111. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 112. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 113. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 114. Merck Recent Development
Table 115. Sanofi Company Details
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 119. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 120. Sanofi Recent Development
Table 121. Serum Company Details
Table 122. Serum Description and Business Overview
Table 123. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 124. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 125. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 126. Serum Recent Development
Table 127. Bavarian Nordic Company Details
Table 128. Bavarian Nordic Description and Business Overview
Table 129. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 130. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 131. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 132. Bavarian Nordic Recent Development
Table 133. Astellas Pharma Company Details
Table 134. Astellas Pharma Description and Business Overview
Table 135. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 137. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 138. Astellas Pharma Recent Development
Table 139. Emergent BioSolutions Company Details
Table 140. Emergent BioSolutions Description and Business Overview
Table 141. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 142. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 143. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 144. Emergent BioSolutions Recent Development
Table 145. GlaxoSmithKline Company Details
Table 146. GlaxoSmithKline Description and Business Overview
Table 147. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 148. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 149. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 150. GlaxoSmithKline Recent Development
Table 151. Pfizer Company Details
Table 152. Pfizer Description and Business Overview
Table 153. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 154. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 155. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 156. Pfizer Recent Development
Table 157. CSL Company Details
Table 158. CSL Description and Business Overview
Table 159. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 160. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021)
Table 161. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share in Global Market
Table 162. CSL Recent Development
Table 163. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
Table 164. Measles, Mumps and Rubella (MMR) Vaccines Customers List
Table 165. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast 2021-2027 (K Doses) & (Million US$)
Table 166. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Type 2021-2027 (K Doses)
Table 167. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Application 2021-2027 (K Doses)
Table 168. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions 2021-2027 (K Doses)
Table 169. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Regions 2021-2027 (Million US$)
Table 170. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Countries 2021-2027 (K Doses)
Table 171. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Countries 2021-2027
Table 172. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Countries 2021-2027 (K Doses)
Table 173. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Countries 2021-2027
Table 174. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions 2021-2027 (K Doses)
Table 175. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Regions 2021-2027 (Million US$)
Table 176. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Countries 2021-2027 (K Doses)
Table 177. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Countries 2021-2027 (Million US$)
Table 178. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Forecast by Regions 2021-2027 (K Doses)
Table 179. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Regions 2021-2027 (Million US$)
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Measles, Mumps and Rubella (MMR) Vaccines Product Picture
Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Shar by Type 2016-2027
Figure 3. Monovalent Vaccine Figures
Figure 4. Polyvalent Vaccine Figures
Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2020 & 2027
Figure 6. Immune Center Use Case
Figure 7. Vaccine Development Agencies and Organizations Use Case
Figure 8. Hospital Use Case
Figure 9. Laboratory Use Case
Figure 10. Biotechnology and Biopharmaceutical Companies Use Case
Figure 11. Measles, Mumps and Rubella (MMR) Vaccines Report Years Considered
Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size 2016-2027 (Million US$)
Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2016-2021 (K Doses)
Figure 14. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Market Share by Regions 2016-2021
Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Regions in 2020
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers in 2020
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Measles, Mumps and Rubella (MMR) Vaccines Sales in 2020
Figure 19. Measles, Mumps and Rubella (MMR) Vaccines Value Share by Manufacturers in 2020
Figure 20. Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers In 2020
Figure 21. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2016-2021)
Figure 23. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 24. Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Price Range (2016-2021)
Figure 25. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2016-2021)
Figure 26. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 27. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 28. U.S. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 29. Canada Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 30. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 31. Germany Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 32. France Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 33. U.K. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 34. Italy Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 35. Russia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 36. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 37. China Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 38. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 39. South Korea Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 40. India Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 41. Australia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 42. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 43. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 44. Thailand Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 45. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 46. Philippines Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 47. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 48. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 49. Mexico Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 50. Brazil Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 51. Argentina Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 52. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Figure 53. Turkey Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 54. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 55. U.A.E Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2016-2021) (K Doses)
Figure 56. Medlmmune Total Revenue (US$ Million): 2020 Compared with 2019
Figure 57. Johnson & Johnson Total Revenue (US$ Million): 2020 Compared with 2019
Figure 58. Merck Total Revenue (US$ Million): 2020 Compared with 2019
Figure 59. Sanofi Total Revenue (US$ Million): 2020 Compared with 2019
Figure 60. Serum Total Revenue (US$ Million): 2020 Compared with 2019
Figure 61. Bavarian Nordic Total Revenue (US$ Million): 2020 Compared with 2019
Figure 62. Astellas Pharma Total Revenue (US$ Million): 2020 Compared with 2019
Figure 63. Emergent BioSolutions Total Revenue (US$ Million): 2020 Compared with 2019
Figure 64. GlaxoSmithKline Total Revenue (US$ Million): 2020 Compared with 2019
Figure 65. Pfizer Total Revenue (US$ Million): 2020 Compared with 2019
Figure 66. CSL Total Revenue (US$ Million): 2020 Compared with 2019
Figure 67. Measles, Mumps and Rubella (MMR) Vaccines Value Chain
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 71. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 72. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 73. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 74. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 75. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 76. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 77. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 78. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Forecast (2021-2027) (K Doses)
Figure 79. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate Forecast (2021-2027) (US$ Million)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
Choose License Type
  • $4250  
  • $6250  
  • $8250  

Secure Payment


img1

Related Reports

Antibody Drug Conjugates Contract Manufacturing Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Therapeutic Drug Monitoring Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More

Topical Drug Delivery System Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More